Anne Vivian-Scott
Algemeen Directeur bij BKIN Technologies Ltd.
Profiel
Anne Vivian-Scott is currently the President & Chief Executive Officer at BKIN Technologies Ltd.
She previously worked as the Vice President-Commercial Development at PARTEQ Innovations.
Ms. Vivian-Scott completed her undergraduate degree at The University of Waterloo.
Actieve functies van Anne Vivian-Scott
| Bedrijven | Functie | Begin |
|---|---|---|
BKIN Technologies Ltd.
 BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Algemeen Directeur | 01-01-2009 |
Eerdere bekende functies van Anne Vivian-Scott
| Bedrijven | Functie | Einde |
|---|---|---|
PARTEQ Innovations
 PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Corporate Officer/Principal | - |
Opleiding van Anne Vivian-Scott
| The University of Waterloo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Finance |
BKIN Technologies Ltd.
BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Health Technology |
